AU2694200A - Itchiness-relieving agents and itchiness-relieving effect potentiators - Google Patents

Itchiness-relieving agents and itchiness-relieving effect potentiators

Info

Publication number: AU2694200A
Authority: AU; Australia
Prior art keywords: itchiness; relieving; agents; potentiators; effect potentiators
Prior art date: 1999-03-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU26942/00A

Other languages

English (en)

Inventor

Fujio Kobayashi

Naruyasu Komorita

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Tanabe Pharma Corp

Original Assignee

Welfide Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-03-01

Filing date

2000-02-25

Publication date

2000-09-21

2000-02-25 Application filed by Welfide Corp filed Critical Welfide Corp

2000-09-21 Publication of AU2694200A publication Critical patent/AU2694200A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU26942/00A 1999-03-01 2000-02-25 Itchiness-relieving agents and itchiness-relieving effect potentiators Abandoned AU2694200A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP11/52143		1999-03-01
JP11052143A JP2000247908A (ja)	1999-03-01	1999-03-01	かゆみ抑制剤
PCT/JP2000/001135 WO2000051640A1 (fr)	1999-03-01	2000-02-25	Agents soulageant les demangeaisons et agents de potentialisation de cet effet de soulagement

Publications (1)

Publication Number	Publication Date
AU2694200A true AU2694200A (en)	2000-09-21

Family

ID=12906663

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU26942/00A Abandoned AU2694200A (en)	1999-03-01	2000-02-25	Itchiness-relieving agents and itchiness-relieving effect potentiators

Country Status (3)

Country	Link
JP (1)	JP2000247908A (fr)
AU (1)	AU2694200A (fr)
WO (1)	WO2000051640A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE333897T1 (de) *	2000-02-22	2006-08-15	Daiichi Asubio Pharma Co Ltd	Arzneimittel mit chymaseinhibitoren als wirksames mittel zur behandlung von dermatitis mit zweiphasigen hautreaktionen
AU2004266536A1 (en) *	2003-08-22	2005-03-03	Teijin Pharma Limited	Drug containing chymase inhibitor as the active ingredient
JP5004590B2 (ja)	2004-12-02	2012-08-22	第一三共株式会社	７員環化合物並びにその製造法および医薬用途
WO2007139230A1 (fr)	2006-05-31	2007-12-06	Asubio Pharma Co., Ltd.	Anneau hétérocycliques à 7 éléments, son procédé de production et ses utilisations pharmaceutiques

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2501671B2 (ja) *	1991-02-04	1996-05-29	救急薬品工業株式会社	高放出性鎮痒貼付剤
JPH06239751A (ja) *	1993-02-15	1994-08-30	Sekisui Chem Co Ltd	炎症性皮膚疾患治療用外用剤
EP0727218A3 (fr) *	1995-02-10	1997-01-15	Suntory Ltd	Compostions antiallergiques contenant de l'ellagitannin du type god comme principe actif
CA2263198A1 (fr) *	1996-09-06	1998-03-12	Nippon Kayaku Kabushiki Kaisha	Nouveaux derives d'acetamide et inhibiteurs de protease
JPH10101666A (ja) *	1996-10-02	1998-04-21	Shionogi & Co Ltd	新規ベンゾオキサシクロトリデシン化合物およびそれを含有する医薬組成物
WO1998018794A1 (fr) *	1996-10-25	1998-05-07	Yoshitomi Pharmaceutical Industries, Ltd.	Nouveaux composes d'amide heterocycliques et leur utilisation a des fins medicinales

1999
- 1999-03-01 JP JP11052143A patent/JP2000247908A/ja active Pending
2000
- 2000-02-25 AU AU26942/00A patent/AU2694200A/en not_active Abandoned
- 2000-02-25 WO PCT/JP2000/001135 patent/WO2000051640A1/fr not_active Ceased

Also Published As

Publication number	Publication date
JP2000247908A (ja)	2000-09-12
WO2000051640A1 (fr)	2000-09-08

Publication	Publication Date	Title
AU7989400A (en)	2001-05-10	Compounds and methods
AU3215500A (en)	2000-08-07	Compounds and methods
AU5826100A (en)	2001-01-30	Benzazepinones and quinazolines
AU3620600A (en)	2000-09-28	Skin-marking devices and their use
AU7101000A (en)	2001-04-10	Microfabrication methods and devices
AU7065200A (en)	2001-03-19	Putting improvement devices and methods
EP1194147A4 (fr)	2002-10-09	Derives d'arylthiazolidinedione et d'aryloxazolidinedione
AU1540001A (en)	2001-06-18	Fluorene-perylene copolymers and uses thereof
AU715620C (en)	2001-11-22	Therapeutic methods and uses
AU2002211717A1 (en)	2002-05-06	Stresscopins and their uses
AU4843500A (en)	2000-12-05	Destructible surfactants and uses thereof
AUPQ342599A0 (en)	1999-11-04	Conjugates and uses thereof
AU6635800A (en)	2001-03-13	Pyridomorphinans, thienomoprhinans and use thereof
AU2001292936A1 (en)	2002-04-02	Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2841801A (en)	2001-07-09	Triazolotriazinones and the use thereof
GB0023323D0 (en)	2000-11-08	Arylhydantoin derivatives and uses thereof
AU7271600A (en)	2001-03-05	Quinazolinone and azaquinazolinone derivatives
AU2001295185A1 (en)	2001-11-07	Multiplexing-interleaving and demultiplexing-deinterleaving
AU1083501A (en)	2001-04-23	Antibiotic-metal complex and methods
AU3732500A (en)	2000-09-28	Beclin and uses thereof
EP1229913A4 (fr)	2005-01-19	1-benzazepines substituees et leurs derives
AU2694200A (en)	2000-09-21	Itchiness-relieving agents and itchiness-relieving effect potentiators
AU5979300A (en)	2001-01-22	Angiopoietin-6 and uses thereof
GB0318113D0 (en)	2003-09-03	›-Secretase enzyme compositions and methods
AU7308300A (en)	2001-05-10	Agents for reducing cholesterol-uptake and liquid-uptake

Legal Events

Date	Code	Title	Description
2002-01-17	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase